Endocare, Inc. is a vertically integrated medical device company that develops, manufactures and markets cryosurgical and stent technologies for applications in oncology and urology. The Company has concentrated on developing devices for the treatment of two common diseases of the prostate, prostate cancer and benign prostate hyperplasia (BPH). The Company is also developing cryosurgical technologies for treating tumors in other organs, including the kidney,breast and liver. Endocare has developed products that include the
Cryocare-4 Probe system, Cryocare-8 Probe System, FastTrac,CryoGuide and Horizon Prostatic Stent.
